跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EMOXEN 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EMOXEN 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Approved
STANDARD
EMOXEN 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Bausch Health Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 21, 2024
Approval ID
0456e20d9cbb5865
Company
Bausch Health Ireland Limited
Type
Standard
Approval Details
Approval Id
0456e20d9cbb5865
Drug Cima Aemps Name
EMOXEN 500 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number
89451
Holder Company Name
Bausch Health Ireland Limited
Marketing Company Name
Bausch Health Ireland Limited
Holder Company Detail Path
/organization/bausch-health-ireland-limited
Marketing Company Detail Path
/organization/bausch-health-ireland-limited
Authorization Date
2024-03-21
Dosage Form
COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose
500 mg/20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Bausch Health Ireland Limited
Company Detail Path
/organization/bausch-health-ireland-limited
Company Information
Pharmaceutical Company Name
BAUSCH HEALTH IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
Citywest Business Campus
Active Ingredients
NAPROXENO
500 mg
ESOMEPRAZOLE MAGNESIO TRIHIDRATO
22,3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 21, 2024
Approval ID
0456e20d9cbb5865
Type
Standard
Back to CIMA-AEMPS Approvals